Form 4: FibroBiologics General Counsel Ruben A. Garcia Granted Stock Options

Ruben A. Garcia, General Counsel of FibroBiologics, Inc., was granted options to purchase 180,000 shares of common stock on March 1, 2024.

Summary

• On March 8, 2024, a Form 4 filing was submitted to the SEC regarding Ruben A. Garcia, General Counsel of FibroBiologics, Inc.
• The filing reports that Mr. Garcia was granted an option to purchase 180,000 shares of FibroBiologics common stock on March 1, 2024.
• The exercise price of the stock option is $13.
• The options vest over a period of four years, with one-fourth vesting on the one-year anniversary of the grant date and the remaining balance vesting in 36 equal monthly installments thereafter, contingent upon continuous service.

Sentiment

Score: 7

Explanation: The granting of stock options is generally viewed positively as it aligns management's interests with shareholders. However, it also represents potential future dilution.

Positives

• The granting of stock options to a key executive like the General Counsel can be seen as an incentive to align their interests with those of the shareholders.

Future Outlook

The vesting schedule of the options incentivizes continued service of the General Counsel over the next four years.

Industry Context

Granting stock options is a common practice in the biotechnology industry to attract and retain key personnel and align their interests with those of the company's shareholders. This aligns with standard compensation practices for executives in similar roles within comparable companies.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead Sciences, and Biogen often use stock options to incentivize their executives.
• The vesting schedule of 4 years is also fairly standard, aligning with industry norms for long-term retention.

Stakeholder Impact

• Shareholders may experience dilution if the options are exercised.
• The grant incentivizes the General Counsel to contribute to the company's success.

Key Dates